Role of helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 9, 2001, Pages 1067-1072

  Miquel, J ^a   Barcena Marugan R ^a   Boixeda, D ^a   Fernandez J ^a   Lopez SanRoman A ^a   Martin de Argila C ^a   Ramosa, F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Ammonaemia; Helicobacter pylori; Liver; Subclinical encephalopathy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; DIURETIC AGENT; LACTULOSE; OMEPRAZOLE; PAROMOMYCIN; UREASE;

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; DRUG EFFECT; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN METABOLISM; PSYCHOMETRY;

ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 0034813686     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200109000-00012     Document Type: Article

References (36)

1. Shenker S. Pathogenesis of Hepatic Encephalopathy. East Lansing: Medi-Ed Press; 1988. pp. 15-30.
2. Aoyagi T, Engstrom GW, Evans WB, Summerskill WH. Gastrointestinal urease in men part I: activity of mucosal urease. Gut 1966; 7: 631-635.
3. Marshall BJ, Warren J. Rapid urease test in the management of Campylobacter pylori associated gastritis. Am J Gastroenterol 1987; 82: 200-210.
4. Blaser MJ. H. pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-633.
5. Graham EA. Seroepidemiology of H. pylori infection in India: comparison of developing and developed countries. Dig Dis Sci 1991; 36: 1084-1088.
6. Wiedmann B, Kircheis G, Klauk S. The influence of H. pylori on protein induced hyperammonaemia in cirrhotic patients without hepatic encephalopathy. Hepatology 1996; 24: 453A.453A.
7. Attili AF, Rinaldi V, Caschera M, Cedola M. H. pylori: a major determinant of serum ammonia levels in cirrhotic patients? [Abstract]. Hepatology 1994; 110A.
8. Rinaldi V, Zullo A, Diana F. Helicobacter pylori, hyperammonemia and hepatic encephalopathy: is there a correlation? Am J Gastroenterol 1997; 92: 723-724.
9. Plevris JN, Morgensten R, Wayes PC, Bouchier IA. Hyperammonaemia in cirrhosis and H. pylori infection. Lancet 1995; 346: 1104.1104.
10. Shigeji I. Hyperammonaemia and H. pylori. Lancet 1995; 346: 124-125.
11. Cho YD, Bong HK, Lee H. The role of gastric H. pylori infection on the blood level of ammonia in patients with liver cirrhosis. Gastroenterology 1997; 112: A8-9.
12. Triebling AT, Korsten MA, Dlugosz JM, Paronetto F, Lieber CS. Severity of H. pylori induced gastric injury correlated with gastric juice ammonia. Dig Dis Sci 1991; 36: 1089-1096.
13. Gubbings G, Moritz TE, Marsano LS, Talwalkar R, McClain CJ, Mendenhall CL. H. pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. Am J Gastroenterol 1993; 88: 1906-1910.
14. Rossle M, Haag K, Oms A. H. pylori is not associated with an increased risk of hepatic encephalopathy. Hepatology 1994; 20: 111.111.
15. Conn H. Test del clavegrama y conexión numérica para determinación del estado mental en la encefalopatía portosistémica. Dig Dis 1977; 22: 541-550.
16. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Kunkel H. Neurophysiological assessment of early encephalopathy. Electroencephalogr Clin Neurophysiol 1990; 75: 289-295.
17. Hollerbach S, Kullmann F, Frund R, Lock G, Geissler A, Scholmerich J. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy: topographic distribution and correlation with clinical and psychometric assessment. Gastroenterology 1997; 44: 1002-1012.
18. Davies M, Rowan MF, MacMathuna P, Keeling PW, Weir DG, Feely J. The auditory P300 event-related potential: an objective marker of the encephalopathy in liver disease. Hepatology 1990; 2: 688-694.
19. Gallai V, Alberti A, Balo S, Mazzotta C, Clerici C, Gentilli G. et al. Cognitive event-related potential in hepatic encephalopathy. Acta Neurol Scand 1995; 91: 358-366.
20. Kugler CF, Lotterer E, Petter J, Wensing G, Taghavy A, Hahn EG, Fleig WF. Visual event-related P300 potentials in early portosystemic encephalopathy. Gastroenterology 1992; 103: 302-310.
21. US Government. War Department Pamphlet no. 12-12: the army individual tests (AIT-1). US Government; April 1991.
22. Doi M, Takasu K, Samuri T. Blood chemical analysis effects of sample collection and subsequent processing on the test results; determination of blood ammonia level by direct deproteinization colorimetry. Rinsho Byori 1996; 103 (suppl): 156-161.
23. Peura DA, Pambiaco DJ, Dye KR, Lind C, Frierson HF, Hoffman SR. Microdose 14C urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol 1996; 91: 233-238.
24. Riordan SM, Williams L. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-479.
25. Neithercut WD, Rone PA, Einujumi AM, Dahill S, McCollke KE. Effect of H. pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol 1993; 46: 544-547.
26. Ito S, Miyaji H, Azuma T, Li Y, Ito Y, Kato T. et al. Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346: 124-125.
27. Ito S, Kholi Y, Kato T. Significance of ammonia produced by Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 167-174.
28. Miyaji K, Ito S, Azuma T. Effects of H. pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997; 40: 726-730.
29. Quero JC, Hartmann L, DeRooij F, Wilson JH, Schalm SW. Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346: 713-714.
30. Mokuolu AO, Sigal SH, Lieber SC. Gastric juice urease activity as a diagnostic test for H. pylori infection. Am J Gastroenterol 1997; 92: 644-648.
31. Dasani B, Sigal S, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 1998; 3: 726-731.
32. Taylor-Robinson SD, Jackson N, Buckley C. Helicobacter pylori, ammonia and the brain. Gut 1997; 40: 805-806.
33. Farinati F, DeBan M, Floreani A, Foschia F, Rugge M. Helicobacter pylori and the brain: any relationship? Ital J Gastroenterol Hepatol 1998; 30: 124-128.
34. Vasconez C, Elizalde JL, Clack J, Gines A, DeCaroso C, Fernández RM. et al. H. pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30: 260-264.
35. Calvet X, Navarro M, Gil M, Mas P, Rivero E, Sanfeliu I. et al. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol 1997; 26: 1249-1254.
36. Martín de Argila C, Boixeda D, Cantón R, Mir N, DeRafael L, Gisbert J. et al. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol 1996; 8: 1165-1168.